title: Contacts to general practice and antidepressant treatment initiation after screening for anxiety and depression in patients with heart disease.
abstract: BACKGROUND
  Anxiety and depression are found in 20-30% of all persons with heart disease, and depression is known to impact mortality. This paper aimed to describe the effect of systematic screening of this population in terms of use of general practice, psychological therapy and antidepressant treatment.
  
  
  METHODS
  A population-based cohort study was conducted in 2011-2013 comprising 1,658 people with heart disease treated at a Danish regional hospital. Collected data were based on Danish national registers and patient questionnaires.
  
  
  RESULTS
  Patients with heart disease and anxiety or depressive symptoms had more general practitioner (GP) contact rates than patients without anxiety or depressive symptoms both before and after the screening. Furthermore, patients with depressive symptoms increased their GP contact rate significantly in the first month after the screening, while this was not the case for patients with anxiety symptoms. Finally, patients with heart disease and anxiety or depressive symptoms more frequently initiated treatment with antidepressants than patients with heart disease without anxiety or depressive symptoms, whereas therapy sessions with a psychologist were rarely used.
  
  
  CONCLUSIONS
  Heart patients with depressive symptoms may benefit from screening for depression, information about the screening result and a subsequent recommendation to consult their GP in case of signs of depression. -However, the observed effect seems to be modest.
  
  
  BACKGROUND
  The study was supported by an unrestricted grant from the Lundbeck Foundation (grant number: R155-2012-11280).
  
  
  BACKGROUND
  none.
authors.affiliation: kkl@alm.au.dk.
authors.forename: Karen Kjær
authors.initials: KK
authors.lastname: Larsen
authors.forename: Claus Høstrup
authors.initials: CH
authors.lastname: Vestergaard
authors.forename: Liv Marit Valen
authors.initials: LM
authors.lastname: Schougaard
authors.forename: Louise Pape
authors.initials: LP
authors.lastname: Larsen
authors.forename: Anne
authors.initials: A
authors.lastname: Jessen
authors.forename: Ole
authors.initials: O
authors.lastname: May
authors.forename: Niels Henrik
authors.initials: NH
authors.lastname: Hjøllund
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D015331:Cohort Studies; D003863:Depression / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D005260:Female; D058006:General Practice / Q000706:statistics & numerical data*; D006296:Health Services / Q000706:statistics & numerical data*; D006331:Heart Diseases / Q000523:psychology*; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011584:Psychology / Q000706:statistics & numerical data; D012017:Referral and Consultation / Q000706:statistics & numerical data
chemical_list: D000928:Antidepressive Agents